The analysis of antidepressant medicine sales in Denmark from 2013 to 2023 shows a significant downward trend, with values decreasing from 366.7 million DKK in 2013 to 146.0 million DKK in 2023. Year-on-year variations reveal substantial fluctuations, with notable declines of over 20% in some years, although occasional increases occurred, such as in 2018 and 2019.
Recent declines have been sharp, with a reduction of 10.7% from 2022 to 2023. The compound annual growth rate (CAGR) over the last five years shows an average annual decrease of 7.58%. Looking forward, sales are forecasted to decline further, with a CAGR of -15.3% from 2024 to 2028, indicating a continuing trend.
Future trends to watch for include:
- Potential impact of newer or alternative treatments for mental health conditions.
- Changes in healthcare policy and insurance coverage impacting antidepressant usage.
- Advancements in personalized medicine might influence prescription behaviors.
